HOME >> BIOLOGY >> NEWS
Chemists characterize regulators of zinc intake and export in cells

EVANSTON, Ill. Chemists at Northwestern University have acquired new insight into how zinc pumps and their regulatory proteins function in cells. The findings, to be published online June 8 in the journal Science, should improve our knowledge of diseases related to zinc metabolism as well as influence future drug design and pharmaceuticals.

Inorganic elements, such as zinc, copper and iron, are vital to the healthy functioning of cells in living organisms, but little is known about how cells use these heavy metals. Each cell in the human body, for instance, requires an enormous amount of zinc, but that amount must be carefully controlled because zinc can be destructive in excess. How does the cell monitor the amount of zinc inside its walls?

Thomas V. OHalloran, professor of chemistry, and Caryn Outten, a former Ph.D. student of OHallorans, have solved an important part of the puzzle. They have described the mechanisms by which two sensor proteins regulate two pumps embedded in the cell membrane. One pump draws zinc into the cell when it is needed, and the other acts as a bouncer, ejecting zinc when the cell is saturated. These are the first and appear to be the primary zinc pumps, along with their regulatory proteins, identified in a cell.

The researchers also have shown that, contrary to current thinking, cells have no free-floating zinc; instead, all zinc is accounted for when in the cell, either bound to proteins or acting as a catalyst in biochemical reactions. This suggests the existence of zinc "chaperone" proteins whose role would be to escort the metal safely to the specific site where it is needed.

"Our work with zinc, copper and other metals involved in human health and disease is helping us to better understand the role these metals play in our body," said OHalloran, who discovered the first copper chaperone protein in 1997.

OHalloran and Outten studied the zinc regulatory proteins in the bacteria E. coli, wh
'"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
6-Jun-2001


Page: 1 2

Related biology news :

1. Chemists at four pharmaceutical companies named Heroes for treating childhood conditions
2. Chemists unlock secret to activating tumor suppressor gene
3. Chemists create unusual lariat RNA, a key intermediate in biological splicing
4. American Institute of Chemists names Ralph Hirschmann AIC Gold Medalist
5. Chemists explore the shape of the key that signals cell division in cancer cells
6. Nanoencapsulation: Chemists at TSRI discover a new and simple way of controlling reactions
7. Chemists spin materials to improve magnetic resonance data
8. Chemists describe "zipper teeth" of DNA molecules -- publish results in the journal Nature
9. Chemists report new approach to synthetic fragments of medically important Heparin
10. Chemists hold national meeting August 22-26
11. Chemists hold national meeting August 22-26 in New Orleans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
Cached News: